On February 27, 2023, John Leaman gave notice of his resignation from his position as the Business Officer and Secretary of Impel Pharmaceuticals Inc. (the “Company”) effective as of March 10, 2023 to pursue another opportunity. The Company has an ongoing search for a successor. On March 2, 2023, Rajiv Amin, the Company's current Vice President, Corporate Controller, was appointed to serve Vice President and Controller, effective March 10, 2023.

In this role, Mr. Amin has assumed the responsibilities of Principal Financial Officer and Principal Accounting Officer. Mr. Amin has served as the Corporate Controller of the Company since 2021. Prior to joining the Company, Mr. Amin has served as a Senior Director of Financial Reporting & Tax at Kyowa Kirin Inc, a pharmaceutical and biotechnology company, in 2021.

From 2019 to 2021, Mr. Amin served as a Controller Americas at Convatec PLC, a publicly traded global vertically integrated medical device company. From 2018 to 2019, he served as a Corporate Controller for Pernix Therapeutics Inc., a publicly traded branded and generic pharmaceuticals company. From 2013 to 2018, Mr. Amin held roles at Alvogen Group Inc. as a Senior Director of Financial Reporting and Technical Accounting and then as a US Controller.

He is a Certified Public Accountant and holds an M.S. in Accounting from Babson College and a B.S. in Accounting from University of Scranton.